Adicet Bio, Inc.
ACET
$0.89
$0.033.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -43.88% | -5.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.39% | -2.79% | |||
| Operating Income | -8.39% | 2.79% | |||
| Income Before Tax | -10.64% | 1.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.64% | 1.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.64% | 1.79% | |||
| EBIT | -8.39% | 2.79% | |||
| EBITDA | -8.98% | 3.14% | |||
| EPS Basic | -10.62% | 2.02% | |||
| Normalized Basic EPS | -10.64% | 2.02% | |||
| EPS Diluted | -10.62% | 2.02% | |||
| Normalized Diluted EPS | -10.64% | 2.02% | |||
| Average Basic Shares Outstanding | 0.02% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||